Trevi Therapeutics (TRVI) Shareholder's Equity (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 172.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172.13 Mn |
| Dec 31, 2025 | 183.24 Mn |
| Sep 30, 2025 | 189.79 Mn |
| Jun 30, 2025 | 198.49 Mn |
| Mar 31, 2025 | 99.46 Mn |
| Dec 31, 2024 | 99.64 Mn |
| Sep 30, 2024 | 58.97 Mn |
| Jun 30, 2024 | 66.17 Mn |
| Mar 31, 2024 | 72.33 Mn |
| Dec 31, 2023 | 82.55 Mn |
| Sep 30, 2023 | 89.61 Mn |
| Jun 30, 2023 | 95.07 Mn |
| Mar 31, 2023 | 101.73 Mn |
| Dec 31, 2022 | 107.46 Mn |
| Sep 30, 2022 | 109.90 Mn |
| Jun 30, 2022 | 60.52 Mn |
| Mar 31, 2022 | 10.46 Mn |
| Dec 31, 2021 | 17.08 Mn |
| Sep 30, 2021 | 11.38 Mn |
| Jun 30, 2021 | 17.74 Mn |
| Mar 31, 2021 | 23.69 Mn |
| Dec 31, 2020 | 27.28 Mn |
| Sep 30, 2020 | 35.62 Mn |
| Jun 30, 2020 | 40.04 Mn |
| Mar 31, 2020 | 46.80 Mn |
| Dec 31, 2019 | 54.55 Mn |
| Sep 30, 2019 | 60.71 Mn |
| Jun 30, 2019 | 67.70 Mn |
| Mar 31, 2019 | -115.48 Mn |
| Dec 31, 2018 | -109.49 Mn |
| Sep 30, 2018 | -102.33 Mn |
| Jun 30, 2018 | -95.34 Mn |
| Mar 31, 2018 | -89.46 Mn |